News & Articles

Industry experts share insights on the elegant technology behind immunoassays and the critical raw materials that make them powerful

For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence

Funding will advance 3D lung cell culture models to accelerate drug discovery

Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019

The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring

Explore hot topics from 3D X-ray microscopy and in vitro diagnostics to gas chromatography and synthetic guide RNAs

The update provides alternative temperature for transportation and temporary storage for frozen vials before dilution

The research brings a deeper understanding about how fructose could be linked to diabetes and obesity

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA

Companion diagnostic can help guide treatment decisions in cases of NSCLC

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella